Reynders McVeigh Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.09M | Buy |
17,904
+112
| +0.6% | +$6.53K | 0.05% | 96 |
|
|
2025
Q4 | $960K | Buy |
17,792
+900
| +5% | +$43.3K | 0.05% | 101 |
|
|
2025
Q3 | $762K | Sell |
16,892
-681
| -4% | -$31.8K | 0.04% | 112 |
|
|
2025
Q2 | $813K | Buy |
17,573
+73
| +0.4% | +$3.58K | 0.04% | 113 |
|
|
2025
Q1 | $1.07M | Sell |
17,500
-374
| -2% | -$21.8K | 0.06% | 92 |
|
|
2024
Q4 | $1.01M | Sell |
17,874
-2,150
| -11% | -$120K | 0.05% | 94 |
|
|
2024
Q3 | $1.04M | Sell |
20,024
-44
| -0.2% | -$2.06K | 0.05% | 95 |
|
|
2024
Q2 | $833K | Buy |
20,068
+223
| +1% | +$9.98K | 0.05% | 102 |
|
|
2024
Q1 | $1.08M | Sell |
19,845
-3,249
| -14% | -$166K | 0.06% | 92 |
|
|
2023
Q4 | $1.19M | Sell |
23,094
-2,039
| -8% | -$107K | 0.08% | 90 |
|
|
2023
Q3 | $1.46M | Sell |
25,133
-181
| -0.7% | -$11.1K | 0.1% | 81 |
|
|
2023
Q2 | $1.62M | Buy |
25,314
+600
| +2% | +$40.2K | 0.11% | 79 |
|
|
2023
Q1 | $1.71M | Sell |
24,714
-776
| -3% | -$54.7K | 0.12% | 76 |
|
|
2022
Q4 | $1.83M | Sell |
25,490
-10
| -0% | -$754 | 0.13% | 74 |
|
|
2022
Q3 | $1.81M | Sell |
25,500
-1,360
| -5% | -$98.7K | 0.14% | 72 |
|
|
2022
Q2 | $2.07M | Buy |
26,860
+4,346
| +19% | +$331K | 0.16% | 65 |
|
|
2022
Q1 | $1.64M | Sell |
22,514
-110
| -0.5% | -$7.39K | 0.1% | 85 |
|
|
2021
Q4 | $1.41M | Sell |
22,624
-673
| -3% | -$39.5K | 0.08% | 92 |
|
|
2021
Q3 | $1.38M | Sell |
23,297
-3,585
| -13% | -$236K | 0.08% | 94 |
|
|
2021
Q2 | $1.8M | Sell |
26,882
-1,730
| -6% | -$113K | 0.11% | 85 |
|
|
2021
Q1 | $1.81M | Sell |
28,612
-1,779
| -6% | -$111K | 0.12% | 86 |
|
|
2020
Q4 | $1.89M | Sell |
30,391
-2,775
| -8% | -$171K | 0.13% | 74 |
|
|
2020
Q3 | $2M | Sell |
33,166
-3,591
| -10% | -$216K | 0.15% | 70 |
|
|
2020
Q2 | $2.16M | Buy |
36,757
+7,635
| +26% | +$457K | 0.19% | 63 |
|
|
2020
Q1 | $1.62M | Sell |
29,122
-1,982
| -6% | -$121K | 0.18% | 68 |
|
|
2019
Q4 | $2M | Buy |
31,104
+4,717
| +18% | +$270K | 0.19% | 71 |
|
|
2019
Q3 | $1.34M | Buy |
26,387
+2,290
| +10% | +$108K | 0.14% | 87 |
|
|
2019
Q2 | $1.09M | Sell |
24,097
-1,165
| -5% | -$54.3K | 0.12% | 96 |
|
|
2019
Q1 | $1.21M | Sell |
25,262
-1,387
| -5% | -$69.1K | 0.13% | 97 |
|
|
2018
Q4 | $1.39M | Sell |
26,649
-650
| -2% | -$34.9K | 0.18% | 78 |
|
|
2018
Q3 | $1.7M | Sell |
27,299
-240
| -0.9% | -$14.2K | 0.2% | 77 |
|
|
2018
Q2 | $1.52M | Sell |
27,539
-619
| -2% | -$33.4K | 0.19% | 79 |
|
|
2018
Q1 | $1.78M | Buy |
28,158
+181
| +0.6% | +$11.6K | 0.23% | 69 |
|
|
2017
Q4 | $1.71M | Sell |
27,977
-794
| -3% | -$49.7K | 0.22% | 73 |
|
|
2017
Q3 | $1.83M | Buy |
28,771
+305
| +1% | +$17.8K | 0.24% | 70 |
|
|
2017
Q2 | $1.59M | Buy |
28,466
+223
| +0.8% | +$12.1K | 0.21% | 75 |
|
|
2017
Q1 | $1.54M | Sell |
28,243
-325
| -1% | -$17.8K | 0.21% | 82 |
|
|
2016
Q4 | $1.67M | Sell |
28,568
-1,200
| -4% | -$65.6K | 0.24% | 76 |
|
|
2016
Q3 | $1.6M | Buy |
29,768
+137
| +0.5% | +$8.8K | 0.23% | 78 |
|
|
2016
Q2 | $2.18M | Buy |
29,631
+1,494
| +5% | +$106K | 0.32% | 62 |
|
|
2016
Q1 | $1.8M | Sell |
28,137
-1,000
| -3% | -$63.1K | 0.27% | 69 |
|
|
2015
Q4 | $2M | Sell |
29,137
-56
| -0.2% | -$3.7K | 0.33% | 57 |
|
|
2015
Q3 | $1.73M | Buy |
29,193
+400
| +1% | +$25.4K | 0.3% | 56 |
|
|
2015
Q2 | $1.92M | Sell |
28,793
-200
| -0.7% | -$13.2K | 0.31% | 51 |
|
|
2015
Q1 | $1.87M | Buy |
28,993
+860
| +3% | +$53.8K | 0.32% | 50 |
|
|
2014
Q4 | $1.66M | Sell |
28,133
-835
| -3% | -$47.1K | 0.29% | 56 |
|
|
2014
Q3 | $1.48M | Buy |
28,968
+1,048
| +4% | +$52.3K | 0.28% | 60 |
|
|
2014
Q2 | $1.35M | Sell |
27,920
-543
| -2% | -$26.8K | 0.31% | 61 |
|
|
2014
Q1 | $1.48M | Buy |
28,463
+1,497
| +6% | +$79.7K | 0.35% | 59 |
|
|
2013
Q4 | $1.43M | Buy |
26,966
+550
| +2% | +$28K | 0.35% | 59 |
|
|
2013
Q3 | $1.22M | Sell |
26,416
-100
| -0.4% | -$4.39K | 0.34% | 60 |
|
|
2013
Q2 | $1.19M | Buy |
+26,516
| New | +$1.15M | 0.35% | 61 |
|
Other funds holding BMY
VCM
VPM
Reynders McVeigh Capital Management's BMY Position: Q1 2026 in Review
Reynders McVeigh Capital Management increased its Bristol-Myers Squibb (BMY) stake by 0.63% in Q1 2026, buying an estimated $6.53K and bringing the position to 17,904 shares worth $1.09M. The position accounts for 0.05% of the portfolio, ranked #96.
Reynders McVeigh Capital Management first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.18M in Q2 2016. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Reynders McVeigh Capital Management held 17,904 shares of Bristol-Myers Squibb worth $1.09M as of Q1 2026.
- Reynders McVeigh Capital Management bought 112 Bristol-Myers Squibb shares in Q1 2026, an estimated $6.53K.
- Bristol-Myers Squibb made up 0.05% of Reynders McVeigh Capital Management's portfolio in Q1 2026, its #96 holding.
- Reynders McVeigh Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Reynders McVeigh Capital Management's Bristol-Myers Squibb position peaked at $2.18M in Q2 2016.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Reynders McVeigh Capital Management's 13F filing for Q1 2026, filed 27 Apr 2026.